Equities
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)452.60
  • Today's Change-3.60 / -0.79%
  • Shares traded461.59k
  • 1 Year change+55.05%
  • Beta0.8005
Data delayed at least 15 minutes, as of Sep 19 2024 16:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..

  • Revenue in DKK (TTM)22.73bn
  • Net income in DKK2.11bn
  • Incorporated2000
  • Employees10.45k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Oci NV1.52bn-6.89bn41.51bn1.15k--6.70--27.24-4.38-0.93910.96993.930.02473.240.4548178,239.80-7.541.31-15.512.10-214.0016.86-305.593.281.37-3.630.5605---47.15-9.6110.45--12.81--
Arkema SA70.31bn2.55bn44.75bn21.10k18.140.77965.400.63664.414.41122.27102.550.65895.456.29449,966.602.585.993.187.2320.7421.463.927.591.3810.280.350431.72-17.631.54-57.64-9.822.786.96
Croda International Plc14.44bn1.44bn49.57bn5.85k34.372.4118.823.431.171.1711.6716.620.45772.364.53278,451.804.6010.805.1112.5143.8646.4110.0518.641.6710.590.234943.44-18.904.09-73.66-6.4212.784.11
Yara International ASA95.09bn1.76bn50.24bn18.00k28.491.035.820.528410.9310.93589.35301.680.88183.447.748,340,167.001.675.302.196.9725.4226.691.895.600.95242.470.380194.60-35.443.60-98.27-21.30-2.76-8.10
Syensqo SA50.49bn164.11m57.27bn13.05k349.191.0112.881.130.20770.207763.9471.640.52043.536.53518,856.300.1768--0.234--33.12--0.3398--1.08--0.2318---13.02---79.68------
Imcd NV33.87bn2.09bn65.36bn5.01k31.175.0021.471.934.934.9379.7430.721.085.535.22958,630.506.667.019.669.6022.3721.406.195.800.88465.670.508744.25-3.4513.30-6.6523.9124.0922.87
Brenntag SE120.92bn4.50bn68.61bn17.96k15.762.109.140.56744.044.04108.4430.291.487.936.40915,370.705.576.407.889.0224.4823.033.764.021.2113.140.44337.40-13.456.03-19.389.1812.47-21.40
Evonik Industries AG112.65bn-678.81m71.26bn32.76k--1.087.370.6326-0.2097-0.209732.0219.030.72783.998.25452,033.90-0.35662.01-0.45022.4227.0225.47-0.492.900.79699.070.3441130.72-17.422.85-186.27---3.510.3454
Akzo Nobel NV79.77bn4.42bn74.52bn35.70k16.882.2410.010.93423.473.4462.4126.170.72883.523.75303,806.804.334.157.186.0640.9040.515.946.070.76684.800.535163.75-1.642.8823.482.2512.321.41
Covestro AG105.28bn-2.42bn77.43bn17.51k--1.5619.700.7354-1.64-1.6473.2335.240.99874.256.79805,593.60-2.343.21-3.064.0815.8220.39-2.353.010.95621.180.299862.45-19.99-0.329227.21--1.59--
Ems Chemie Holding AG16.59bn3.66bn124.79bn2.77k34.087.8830.437.5219.7519.7589.4685.440.8586--6.07764,838.1019.1322.7222.1127.29--45.0222.2823.253.72245.250.015387.87-10.36-1.14-14.01-2.51-3.871.57
Symrise AG36.42bn2.93bn125.64bn12.54k42.954.4823.873.452.812.8134.9226.900.61862.404.94392,584.405.024.995.805.9537.1037.938.118.131.647.170.40143.832.428.4421.594.043.444.10
Novozymes A/S22.73bn2.11bn189.07bn10.45k65.842.5840.048.326.936.9367.34176.650.322.665.053,552,918.002.9613.463.4317.8446.6755.569.2520.120.68712.090.153138.891.824.47-17.86-1.288.124.41
Data as of Sep 19 2024. Currency figures normalised to Novozymes A/S's reporting currency: Danish Krone DKK

Institutional shareholders

14.54%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Sep 202412.17m2.94%
Norges Bank Investment Managementas of 31 Dec 20238.85m2.13%
APG Asset Management NVas of 31 Dec 20237.59m1.83%
BlackRock Fund Advisorsas of 05 Sep 20246.31m1.52%
Impax Asset Management Ltd.as of 30 Aug 20244.97m1.20%
GuardCap Asset Management Ltd.as of 31 Jul 20244.94m1.19%
Geode Capital Management LLCas of 12 Sep 20244.35m1.05%
Handelsbanken Fonder ABas of 31 Aug 20244.10m0.99%
MFS International (UK) Ltd.as of 31 Jul 20243.76m0.91%
Baillie Gifford & Co.as of 31 Aug 20243.24m0.78%
More ▼
Data from 30 Jun 2024 - 31 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.